Response to: 'Correspondence on 'Anti-inflammatory therapy for COVID-19 infection: the case for colchicine'' by Perricone et al
- PMID: 33509798
- DOI: 10.1136/annrheumdis-2021-219898
Response to: 'Correspondence on 'Anti-inflammatory therapy for COVID-19 infection: the case for colchicine'' by Perricone et al
Keywords: COVID-19; inflammation; therapeutics.
Conflict of interest statement
Competing interests: None declared.
Comment on
-
Anti-inflammatory therapy for COVID-19 infection: the case for colchicine.Ann Rheum Dis. 2021 May;80(5):550-557. doi: 10.1136/annrheumdis-2020-219174. Epub 2020 Dec 8. Ann Rheum Dis. 2021. PMID: 33293273 Free PMC article. Review.
-
Correspondence on 'Anti-inflammatory therapy for COVID-19 infection: the case for colchicine'.Ann Rheum Dis. 2023 Apr;82(4):e81. doi: 10.1136/annrheumdis-2021-219872. Epub 2021 Jan 28. Ann Rheum Dis. 2023. PMID: 33509794 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
